LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 93 filers reported holding LYELL IMMUNOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $42,132 | -58.0% | 28,661 | -9.1% | 0.03% | -55.9% |
Q2 2023 | $100,227 | +49.4% | 31,518 | +10.9% | 0.06% | +59.5% |
Q1 2023 | $67,074 | -50.9% | 28,421 | -27.8% | 0.04% | -47.9% |
Q4 2022 | $136,527 | -19.2% | 39,345 | +70.2% | 0.07% | +6.0% |
Q3 2022 | $169,000 | +12.7% | 23,117 | +0.8% | 0.07% | +19.6% |
Q2 2022 | $150,000 | – | 22,943 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 20,162,332 | $101,820,000 | 43.09% |
Apoletto Ltd | 15,093,969 | $76,225,000 | 20.06% |
Foresite Capital Management IV, LLC | 13,282,181 | $67,075,000 | 18.76% |
HSG Holding Ltd | 3,045,997 | $15,382,000 | 1.92% |
MIC Capital Management UK LLP | 1,320,000 | $6,666,000 | 1.30% |
Alphabet Inc. | 5,865,125 | $29,619,000 | 0.96% |
Board of Trustees of The Leland Stanford Junior University | 1,647,882 | $8,322,000 | 0.47% |
Adero Partners, LLC | 253,512 | $1,280,000 | 0.19% |
Artal Group S.A. | 700,000 | $3,535,000 | 0.15% |
Eagle Health Investments LP | 100,000 | $505,000 | 0.12% |